Page 89 - GPD-3-1
P. 89

Gene & Protein in Disease                                        Stress-induced epigenetics of the DRD2 gene



            73.  Ross SE, Bogdanovic O. TET enzymes, DNA demethylation   2011;108(3):378-396.
               and pluripotency. Biochem Soc Trans. 2019;47(3):875-885.
                                                                  doi: 10.1161/CIRCRESAHA.110.224287
               doi: 10.1042/BST20180606
                                                               86.  Beermann J, Piccoli MT, Viereck J, Thum T. Non-
            74.  An J, González-Avalos E, Chawla A, et al. Acute loss of TET   coding RNAs in development and disease: Background,
               function results in aggressive myeloid cancer in mice. Nat   mechanisms, and therapeutic approaches.  Physiol Rev.
               Commun. 2015;6:10071.                              2016;96(4):1297-1325.
               doi: 10.1038/ncomms10071                           doi: 10.1152/physrev.00041.2015
            75.  Dalton SR, Bellacosa A. DNA demethylation by TDG.   87.  Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet.
               Epigenomics. 2012;4(4):459-467.                    2006;15(Spec No 1):R17-R29.
               doi: 10.2217/epi.12.36                             doi: 10.1093/hmg/ddl046
            76.  Zentner GE, Henikoff S. Regulation of nucleosome   88.  Blum K, Noble EP, Sheridan PJ, et al. Allelic association of
               dynamics by histone modifications.  Nat Struct Mol Biol.   human dopamine D2 receptor gene in alcoholism. JAMA.
               2013;20(3):259-266.                                1990;263(15):2055-2060.
               doi: 10.1038/nsmb.2470                          89.  Thompson J, Thomas N, Singleton A, et al. D2 dopamine
                                                                  receptor gene (DRD2) Taq1 A polymorphism: Reduced
            77.  Tessarz P, Kouzarides T. Histone core modifications   dopamine D2 receptor binding in the human striatum
               regulating nucleosome structure and dynamics. Nat Rev Mol   associated with the A1 allele.  Pharmacogenetics.
               Cell Biol. 2014;15(11):703-708.                    1997;7(6):479-484.
               doi: 10.1038/nrm3890                               doi: 10.1097/00008571-199712000-00006
            78.  Stillman B. Histone modifications: Insights into their   90.  Savitz J, Hodgkinson CA, Martin-Soelch C,  et al.
               influence on gene expression. Cell. 2018;175(1):6-9.  DRD2/ANKK1 Taq1A polymorphism (rs1800497) has
               doi: 10.1016/j.cell.2018.08.032                    opposing effects on D2/3 receptor binding in healthy
                                                                  controls and patients with major depressive disorder. Int J
            79.  Zhao Z, Shilatifard A. Epigenetic modifications of histones   Neuropsychopharmacol. 2013;16(9):2095-2101.
               in cancer. Genome Biol. 2019;20(1):245.
                                                                  doi: 10.1017/S146114571300045X
               doi: 10.1186/s13059-019-1870-5
                                                               91.  Schellekens AF, Franke B, Ellenbroek B,  et  al. Reduced
            80.  Gräff J, Tsai LH. Histone acetylation: Molecular mnemonics   dopamine receptor sensitivity as an intermediate phenotype
               on the chromatin. Nat Rev Neurosci. 2013;14(2):97-111.  in alcohol dependence and the role of the COMT Val158Met
               doi: 10.1038/nrn3427                               and DRD2 Taq1A genotypes.  Arch Gen Psychiatry.
                                                                  2012;69(4):339-348.
            81.  Hyland EM, Cosgrove MS, Molina H,  et  al. Insights into
               the role of histone H3 and histone H4 core modifiable      doi: 10.1001/archgenpsychiatry.2011.1335
               residues  in  Saccharomyces  cerevisiae.  Mol  Cell Biol.   92.  Benton D, Young HA. A meta-analysis of the relationship
               2005;25(22):10060-10070.                           between brain dopamine receptors and obesity: A matter of
               doi: 10.1128/MCB.25.22.10060-10070.2005            changes in behavior rather than food addiction? Int J Obes
                                                                  (Lond). 2016;40(Suppl 1):S12-S21.
            82.  Varela RB, Resende WR, Dal-Pont GC,  et al. Role of
               epigenetic regulatory enzymes in animal models of mania      doi: 10.1038/ijo.2016.9
               induced by amphetamine and paradoxical sleep deprivation.   93.  Eisenstein SA, Bogdan R, Love-Gregory L, et al. Prediction
               Eur J Neurosci. 2021;53(2):649-662.                of striatal D2 receptor binding by DRD2/ANKK1 TaqIA
                                                                  allele status. Synapse. 2016;70(10):418-431.
               doi: 10.1111/ejn.14922
                                                                  doi: 10.1002/syn.21916
            83.  Kim S, Kaang BK. Epigenetic regulation and chromatin
               remodeling in learning and memory.  Exp Mol Med.   94.  Shi S, Leites C, He D, et al. MicroRNA-9 and microRNA-326
               2017;49(1):e281.                                   regulate human dopamine D2 receptor expression, and the
                                                                  microRNA-mediated expression regulation is altered by a
               doi: 10.1038/emm.2016.140
                                                                  genetic variant. J Biol Chem. 2014;289(19):13434-1344.
            84.  Clapier CR, Cairns BR. The biology of chromatin remodeling      doi: 10.1074/jbc.M113.535203
               complexes. Annu Rev Biochem. 2009;78:273-304.
                                                               95.  Völter C, Riedel M, Wöstmann N,  et al. Sensorimotor
               doi: 10.1146/annurev.biochem.77.062706.153223
                                                                  gating and D2 receptor signalling: Evidence from a
            85.  Han P, Hang CT, Yang J, Chang CP. Chromatin remodeling   molecular genetic approach.  Int J Neuropsychopharmacol.
               in cardiovascular development and physiology.  Circ Res.   2012;15(10):1427-1440.


            Volume 3 Issue 1 (2024)                         16                       https://doi.org/10.36922/gpd.1966
   84   85   86   87   88   89   90   91   92   93   94